國立虎尾科技大學 |

High-density lipoproteins as biomarkers and therapeutic tools.. Volume 1,. Impacts of lifestyle, diseases, and environmental stressors on HDL

Record Type:	Language materials, printed : Monograph/item
Title/Author:	High-density lipoproteins as biomarkers and therapeutic tools./ by Kyung-Hyun Cho.
remainder title:	Impacts of lifestyle, diseases, and environmental stressors on HDL
Author:	Cho, Kyung-Hyun.
Published:	Singapore :Springer Singapore : : 2019.,
Description:	xxiv, 383 p. :ill., digital ; : 24 cm.;
Contained By:	Springer eBooks
Subject:	High density lipoproteins. -
Online resource:	https://doi.org/10.1007/978-981-13-7387-9
ISBN:	9789811373879

High-density lipoproteins as biomarkers and therapeutic tools.. Volume 1,. Impacts of lifestyle, diseases, and environmental stressors on HDL
Cho, Kyung-Hyun.

High-density lipoproteins as biomarkers and therapeutic tools.Volume 1,Impacts of lifestyle, diseases, and environmental stressors on HDL[electronic resource] /Impacts of lifestyle, diseases, and environmental stressors on HDLby Kyung-Hyun Cho. - Singapore :Springer Singapore :2019. - xxiv, 383 p. :ill., digital ;24 cm.

Preface -- Chapter 1. Understanding HDL: overview -- 1-1.HDL and disease -- 1-2.HDL functions and clinical applications -- 1-3.HDL composition : apolipoproteins and enzymes -- 1-4.Maturation of HDL -- 1-5.HDL and blood pressure -- Chapter 2. Change of HDL by life style -- 2-1.Exercise and HDL -- 2-2.Smoking and HDL -- 2-3.Elderly's HDL -- 2-4.HDL depends on body weight -- 2-5.HDL from obese but healthy subject -- 2-6.HDL and apoA-I in smokers' breast milk -- 2-7.Breast milk from frequent trans fatty acid consumers -- 2-8.HDL in cord blood from small neonates -- Chapter 3. Change of HDL in various diseases -- 3-1.HDL from patients with myocardial infarction -- 3-2.HDL from patients with female angina pectoris -- 3-3.HDL and metabolic syndrome -- 3-4.HDL from male patients with atrial fibrillation -- 3-5.HDL from female patients with atrial fibrillation -- 3-6.HDL from patients with hemorrhagic fever with renal syndrome -- 3-7.HDL from patients with rheumatoid arthritis -- 3-8.HDL and prehypertension -- Chapter 4. Detriment of HDL by pollutant and its evaluation -- 4-1.Particulate matter and HDL -- 4-2.Phthalate and HDL -- 4-3.Cadmium and HDL -- 4-4.Humidifier Sterilizer and HDL -- 4-5.Detection of dysfunctional HDL by microfluidics -- 4-6.Evaluation of dysfunctional HDL using zebrafish embryo -- Chapter 5. Change of HDL by food ingredient -- 5-1.Fructose and apoA-I -- 5-2.Fructose and impairment of HDL functionality -- 5-3.Artificial sweeteners and apoA-I -- 5-4.Artificial sweeteners (aspartame, saccharin) and HDL -- 5-5.Aldoketohexoses and HDL -- 5-6.Iron and HDL -- 5-7.Trans fat and HDL -- 5-8.Salt and HDL 576 p -- Summary and perspectives.

This book is the first of two volumes that offer a comprehensive, up-to-date account of current knowledge regarding high-density lipoprotein (HDL), the changes that occur in HDL under different conditions, the clinical applications of HDL, and means of enhancing HDL functionality. HDL comprises a diverse group of lipoproteins and its composition and metabolism are dynamic. In this volume, the focus is on the changes observed in HDL under different health statuses, with particular attention to the functional and structural correlations of HDL and apolipoprotein A-1. The impacts of a wide variety of factors on HDL are examined in depth, covering, for example, diet, exercise, smoking, age, diverse diseases, and different forms of environmental pollution. It has long been known that HDL has anti-atherosclerotic and antidiabetic properties, and more recently its anti-aging activities have been recognized. These benefits of HDL are highly dependent on its lipids, proteins, apolipoproteins, and enzymes, and specifically their composition and ratios. In documenting the latest knowledge in this field, this volume will be of interest to both researchers and clinicians.

ISBN: 9789811373879

Standard No.: 10.1007/978-981-13-7387-9doiSubjects--Topical Terms:

1064869
High density lipoproteins.

LC Class. No.: QP99.3.H53 / C465 2019

Dewey Class. No.: 572.68

High-density lipoproteins as biomarkers and therapeutic tools.. Volume 1,. Impacts of lifestyle, diseases, and environmental stressors on HDL
LDR:04029nam a2200349 a 4500 001 940172
003 DE-He213
005 20191016145422.0
006 m d
007 cr nn 008maaau
008 200417s2019 si s 0 eng d
020 $a 9789811373879 $q (electronic bk.)
020 $a 9789811373862 $q (paper)
024 7 $a 10.1007/978-981-13-7387-9 $2 doi
035 $a 978-981-13-7387-9
040 $a GP $c GP
041 0 $a eng
050 4 $a QP99.3.H53 $b C465 2019
072 7 $a MBGR $2 bicssc
072 7 $a SCI049000 $2 bisacsh
072 7 $a MBGR $2 thema
072 7 $a PSD $2 thema
082 0 4 $a 572.68 $2 23
090 $a QP99.3.H53 $b C545 2019
100 1 $a Cho, Kyung-Hyun. $3 1226693
245 1 0 $a High-density lipoproteins as biomarkers and therapeutic tools. $n Volume 1, $p Impacts of lifestyle, diseases, and environmental stressors on HDL $h [electronic resource] / $c by Kyung-Hyun Cho.
246 3 0 $a Impacts of lifestyle, diseases, and environmental stressors on HDL
260 $a Singapore : $c 2019. $b Springer Singapore : $b Imprint: Springer,
300 $a xxiv, 383 p. : $b ill., digital ; $c 24 cm.
505 0 $a Preface -- Chapter 1. Understanding HDL: overview -- 1-1.HDL and disease -- 1-2.HDL functions and clinical applications -- 1-3.HDL composition : apolipoproteins and enzymes -- 1-4.Maturation of HDL -- 1-5.HDL and blood pressure -- Chapter 2. Change of HDL by life style -- 2-1.Exercise and HDL -- 2-2.Smoking and HDL -- 2-3.Elderly's HDL -- 2-4.HDL depends on body weight -- 2-5.HDL from obese but healthy subject -- 2-6.HDL and apoA-I in smokers' breast milk -- 2-7.Breast milk from frequent trans fatty acid consumers -- 2-8.HDL in cord blood from small neonates -- Chapter 3. Change of HDL in various diseases -- 3-1.HDL from patients with myocardial infarction -- 3-2.HDL from patients with female angina pectoris -- 3-3.HDL and metabolic syndrome -- 3-4.HDL from male patients with atrial fibrillation -- 3-5.HDL from female patients with atrial fibrillation -- 3-6.HDL from patients with hemorrhagic fever with renal syndrome -- 3-7.HDL from patients with rheumatoid arthritis -- 3-8.HDL and prehypertension -- Chapter 4. Detriment of HDL by pollutant and its evaluation -- 4-1.Particulate matter and HDL -- 4-2.Phthalate and HDL -- 4-3.Cadmium and HDL -- 4-4.Humidifier Sterilizer and HDL -- 4-5.Detection of dysfunctional HDL by microfluidics -- 4-6.Evaluation of dysfunctional HDL using zebrafish embryo -- Chapter 5. Change of HDL by food ingredient -- 5-1.Fructose and apoA-I -- 5-2.Fructose and impairment of HDL functionality -- 5-3.Artificial sweeteners and apoA-I -- 5-4.Artificial sweeteners (aspartame, saccharin) and HDL -- 5-5.Aldoketohexoses and HDL -- 5-6.Iron and HDL -- 5-7.Trans fat and HDL -- 5-8.Salt and HDL 576 p -- Summary and perspectives.
520 $a This book is the first of two volumes that offer a comprehensive, up-to-date account of current knowledge regarding high-density lipoprotein (HDL), the changes that occur in HDL under different conditions, the clinical applications of HDL, and means of enhancing HDL functionality. HDL comprises a diverse group of lipoproteins and its composition and metabolism are dynamic. In this volume, the focus is on the changes observed in HDL under different health statuses, with particular attention to the functional and structural correlations of HDL and apolipoprotein A-1. The impacts of a wide variety of factors on HDL are examined in depth, covering, for example, diet, exercise, smoking, age, diverse diseases, and different forms of environmental pollution. It has long been known that HDL has anti-atherosclerotic and antidiabetic properties, and more recently its anti-aging activities have been recognized. These benefits of HDL are highly dependent on its lipids, proteins, apolipoproteins, and enzymes, and specifically their composition and ratios. In documenting the latest knowledge in this field, this volume will be of interest to both researchers and clinicians.
650 0 $a High density lipoproteins. $3 1064869
650 1 4 $a Molecular Medicine. $3 668353
650 2 4 $a Pharmaceutical Sciences/Technology. $3 768561
650 2 4 $a Biomedical Engineering/Biotechnology. $3 1068811
650 2 4 $a Diabetes. $3 582755
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer eBooks
856 4 0 $u https://doi.org/10.1007/978-981-13-7387-9
950 $a Biomedical and Life Sciences (Springer-11642)